美国 · 平台与数据 · Stocktwits

Compass Pathways To Complete COMP360 FDA Filing Within Two Weeks — CEO Nath Eyes Launch In First Half Of 2027

来源：Stocktwits · 美国 11 小时前

The drugmaker reported a diluted net loss of $0.31 per share in Q3, beating analysts’ expectations of a $0.41 per share loss, according to Fiscal.ai. Compass ended September with…

在 Stocktwits 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)

Compass Pathways To Complete COMP360 FDA Filing Within Two Weeks — CEO Nath Eyes Launch In First Half Of 2027

推荐阅读

Needham & Company LLC Issues Pessimistic Forecast for Cipher Mining (NASDAQ:CIFR) Stock Price

Revvity rises on full-year guidance boost

Warren Buffett Has 1 Simple Rule for Investing During Bear Markets. History Says He's Right.

Stock market after midterm elections: What S&P 500 history shows

Myro (MYRO) Price Prediction: 2025, 2026, 2030

5 questions to ask if your boss offers you a buyout, as Microsoft did with 60,000 employees

Compass Pathways To Complete COMP360 FDA Filing Within Two Weeks — CEO Nath Eyes Launch In First Half Of 2027

分享

推荐阅读

Needham & Company LLC Issues Pessimistic Forecast for Cipher Mining (NASDAQ:CIFR) Stock Price

Revvity rises on full-year guidance boost

Warren Buffett Has 1 Simple Rule for Investing During Bear Markets. History Says He's Right.

Stock market after midterm elections: What S&P 500 history shows

Myro (MYRO) Price Prediction: 2025, 2026, 2030

5 questions to ask if your boss offers you a buyout, as Microsoft did with 60,000 employees